Clinical Trials Browser

Phase 2 × sovateltide × Clear all

NCT01741155 2021-10-13

Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT01773785 2021-10-13

Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms